LIVE
NIFTY 5022,453.30+0.98%SENSEX74,235.62+1.24%BANK NIFTY48,892.15+1.45%NIFTY IT35,124.80-0.52%NIFTY MIDCAP52,487.25+0.87%NIFTY 5022,453.30+0.98%SENSEX74,235.62+1.24%BANK NIFTY48,892.15+1.45%NIFTY IT35,124.80-0.52%NIFTY MIDCAP52,487.25+0.87%

Aurobindo Pharma Secures FTC Approval for Lannett Acquisition

By SivamAurobindo Pharma Secures FTC Approval for Lannett Acquisition

Aurobindo Pharma USA Inc. receives US FTC approval to acquire Lannett Company LLC, expanding its US manufacturing and diversifying into high-value generics.

Aurobindo Pharma USA Inc. has secured key approval from the US Federal Trade Commission (FTC) for its acquisition of Lannett Company LLC. This clearance marks a significant step for Aurobindo’s strategic expansion in the highly competitive U.S. generics market.

The Deal Details

  • Aurobindo Pharma USA Inc. will acquire 100% of the membership interest in Lannett Company LLC from Lannett Seller Holdco, Inc.
  • The subsidiary had previously signed a definitive agreement for this transaction.

Strategic Implications

This transaction is set to bolster Aurobindo’s presence and capabilities in the United States. It aligns with the company’s objective to:

  • Expand its U.S. manufacturing footprint and enhance existing domestic capabilities.
  • Strengthen its ability to serve the U.S. generics space effectively.
  • Achieve strategic diversification into a specialized, high-value therapeutic category.
Home/business/Article
    Aurobindo Pharma Secures FTC Approval for Lannett Acquisition | The PIP | The PIP